Tympanogen, Inc. is a medical device company whose mission is to set a new standard of care for treating chronic tympanic membrane perforations. These perforations often result from pressure-equalizing tubes needed to relieve middle ear infections. If left untreated, these perforations may lead to recurrent infection, hearing loss, nerve, and brain damage. Current therapies require invasive surgeries with potentially low success rates.
Our patent-pending gel patch product, called Perf-FixTM, replaces the current surgical therapy with an in-clinic procedure. Preliminary studies have shown Perf-Fix TM to double the success rate of the current surgical procedure while actively preventing recurrent infection. Perf-FixTM is the singular nonsurgical alternative among currently available products.
Perf-FixTM is still in development, and is not for sale in the United States or any country.